HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Trudel, M. Articles by Lacroix, M. Search for Related Content PubMed PubMed Citation Articles by Trudel, M. Articles by Lacroix, M. Agricola Articles by Trudel, M. Articles by Lacroix, M.

Identification of a Synthetic Peptide as Part of a Major Neutralization Epitope of Respiratory Syncytial Virus

¹ Centre de Recherche en Virologie
² IAF BioChem International Inc.
and³ Division des Produits Biochimiques, Institut Armand Frappier, Université du Québec, 531 boulevard des Prairies, C.P. 100, Laval, Québec, Canada H7N 4Z3

A 7000 M_r cleavage fragment of the F1 subunit that carries the major neutralization epitope has been identified by chemical and enzymatic cleavage of the fusion protein of respiratory syncytial (RS) virus (Long strain) with an efficient RS virus-neutralizing monoclonal antibody. Based on the published mRNA-deduced sequence of the A2 strain, coupled to the hydropathicity profile and prediction of protein conformation, the neutralization epitope has tentatively been localized on the first third of the F1 protein N-terminal, probably in the region of amino acids 215Ser to 236Glu. Analysis of three peptides covering different portions of the 212Cys to 236Glu region of the F1 fusion protein identified a peptide (Cys·216Asn to 236Glu) that reacted strongly with the neutralizing monoclonal antibody and that was efficient in blocking neutralization and in plaque-reducing assays, confirming that the neutralization epitope was localized in that region. Further analysis with two other synthetic peptides (212Cys to 222Glu and Cys·221Ile to 236Glu) indicated that the dodecapeptide Ile-Glu-Phe-Gln-Lys-Asn-Asn-Arg-Leu-Leu-Glu mimicked either the whole or a major part of the neutralization epitope. This opens a promising avenue for the simple design of a synthetic peptide vaccine to control RS virus infection.

Keywords: RSV, neutralization epitope, synthetic peptide

Received 24 February 1987; accepted 2 June 1987.

This article has been cited by other articles:

				S.-J. Wu, A. Schmidt, E. J. Beil, N. D. Day, P. J. Branigan, C. Liu, L. L. Gutshall, C. Palomo, J. Furze, G. Taylor, et al. Characterization of the epitope for anti-human respiratory syncytial virus F protein monoclonal antibody 101F using synthetic peptides and genetic approaches J. Gen. Virol., October 1, 2007; 88(10): 2719 - 2723. [Abstract] [Full Text] [PDF]

				H. BELANGER, N. FLEYSH, S. COX, G. BARTMAN, D. DEKA, M. TRUDEL, H. KOPROWSKI, and V. YUSIBOV Human respiratory syncytial virus vaccine antigen produced in plants FASEB J, November 1, 2000; 14(14): 2323 - 2328. [Abstract] [Full Text]

				J. A. Lopez, R. Bustos, C. Orvell, M. Berois, J. Arbiza, B. Garcia-Barreno, and J. A. Melero Antigenic Structure of Human Respiratory Syncytial Virus Fusion Glycoprotein J. Virol., August 1, 1998; 72(8): 6922 - 6928. [Abstract] [Full Text] [PDF]